Paulson Investments / AspenBio Pharma, Inc.
Did Paulson Investments, through Michael McGinley or any other of its Registered Representatives, recommend the purchase of AspenBio Pharma, Inc., for your portfolio? Levin, Papantonio is investigating whether these recommendations were made based on inside information, and whether the information provided by Paulson Investments was accurate.
If you purchased AspenBio Phamra, Inc. based on the recommendations of Paulson Investments and its representatives, you may have a claim against your brokerage firm. Investors who relied on Paulson Investments to construct their portfolios and who held AspenBio Pharma may be entitled to recover their losses. Please contact Peter Mougey at Levin, Papantonio to explore your potential claim.
The American Trial Lawyer
publishes article Financial Meth Labs by Peter Mougey - Morgan Keegan and Goldman Sachs charged with fraud by Securities Regulators
Wall Street Journal
Peter Mougey quoted in WSJ article "Arbitrator Out of Work? Call Finra"
Barrons
Peter Mougey quoted in Barrons article "Taking Aim at the Brokers"
Pensacola News Journal
Pension Funds Pursue Merrill Lynch - Peter Mougey advocates for investors rights
InvestmentNews
Morgan Keegan faces mass of bond fund claims
BBC
Story of a sub-prime mortgage
Los Angeles Times
Front page article quotes attorney Peter Mougey on retiree nest egg investment fraud
Business Week
quotes attorney Peter Mougey on brokers selling toxic debt to seniors
The American Trial Lawyer
publishes article by Peter Mougey on financial abuse by Morgan Keegan brokers
Indianapolis Business Journal
interviews attorney Peter Mougey over Merrill Lynch firing broker after theft allegations
Business Week
quotes attorney Peter Mougey on brokers epidemic 'why work' pitch
Independant News
talks to Peter Mougey about Morgan Keegan fund meltdown
Kipilinger's Retirement Report quotes Mougey on retiree brokers' use of fraudulent sales pitches
South Florida Business Journal quotes Peter Mougey on securities class actions
